Fatigue dans la MG : facteurs de risques et impacts sur la qualité de vie

Rubrique ouverte à tous en lecture seule.
POUR ACCEDER AUX NOMBREUX AUTRES FORUMS IL EST NECESSAIRE DE S'INSCRIRE (fonction M'enregistrer en haut à droite de l'écran).
Avatar du membre

Auteur du sujet
Messages : 5291
Enregistré le : 02 févr. 2010 18:41
Localisation : La Chapelle en Serval F-60520
    Windows 8.1 Firefox
Genre :
Zodiaque :
Âge : 61
Contact :

Fatigue dans la MG : facteurs de risques et impacts sur la qualité de vie

Message par Pboulanger » 11 août 2016 11:20


Lu sur http://onlinelibrary.wiley.com/doi/10.1 ... avedsearch
Traduction disponible directement en cliquant en bas à droite de ce message sur notre forum

Fatigue in myasthenia gravis: risk factors and impact on quality of life
Authors Sarah Hoffmann 1,2  | Johanna Ramm 1  | Ulrike Grittner 3,4  | Siegfried Kohler 1,2  |
Jana Siedler 1  | Andreas Meisel 1,2
First published: 2 August 2016Full publication history
DOI: 10.1002/brb3.538

  • Objectives:

    Emerging evidence suggests that fatigue in myasthenia gravis (MG) is a relevant problem that negatively impacts activities of daily living (ADL). The relation-ship between fatigue and quality of life (QoL) has never been systematically explored in MG patients. The study aimed to assess the revalence of fatigue and its relation to ADL and QoL as well as to identify factors associated with fatigue in MG.
  • Material and methods:

    This was a cross- sectional observational study in patients with confirmed diagnosis of MG independent of disease severity. Prevalence of fatigue was
    assessed using the Chalder Fatigue Scale (CFQ). Impact of fatigue on ADL and QoL was assessed by the MG activities of daily living profile (MG- ADL) and the MG- specific quality- of- life instrument (MG- QoL), respectively. Association of fatigue with sociode-mographics, clinical characteristics of MG, and comorbidities including mood and anxi-ety disorders as well as sleep disorders was investigated using multivariable logistic regression analyses.
  • Results:

    Overall, 200 MG patients were included. The observed rate of fatigue was 56.1%, of those 70.4% fulfilled the criteria of chronic fatigue (CF) with a duration of ≥6 months. Relevant fatigue was strongly associated to ADL and QoL. Factors associated with relevant fatigue were disease severity and depressive state. Furthermore, positive muscle- specific tyrosine kinase (MuSK) antibody status showed a strong association with relevant fatigue.
  • Conclusions:

    MG patients have a high prevalence of fatigue which negatively impacts ADL and QoL. MG- specific clinical characteristics are related to fatigue and might help to identify MG patients at risk for fatigue.


Retourner vers « Informations »